Related articles

Mistletoe (Viscum album) has been used in integrative oncology for decades as an adjunct therapy for cancer patients. Intravenous (IV) mistletoe therapy is believed to have immune-modulating, anti-cancer, and quality-of-life-enhancing properties. It is widely used in Europe, particularly in Germany and Switzerland, as part of complementary cancer care. This article explores the scientific mechanisms, clinical evidence, and potential benefits of IV mistletoe therapy in cancer treatment.

Hyperthermia, or therapeutic heat therapy, involves raising the temperature of tumor tissues to enhance cancer treatment. Research shows that hyperthermia can increase the effectiveness of chemotherapy, radiation therapy, and immunotherapy while directly inducing cancer cell death. This article explores the scientific mechanisms, clinical evidence, and therapeutic potential of hyperthermia for cancer patients.

Oxyhydrogen gas (HHO), a mixture of hydrogen (H₂) and oxygen (O₂) gases, has gained attention in integrative oncology due to its potential antioxidant, antiinflammatory, and anticancer properties. Research suggests that inhaling oxyhydrogen gas may help reduce oxidative stress, modulate immune responses, and enhance overall cellular function. This article explores the scientific mechanisms, clinical evidence, and potential benefits of oxyhydrogen gas therapy for cancer patients.

Vitamin D plays a crucial role in maintaining overall health, particularly in bone metabolism, immune function, and inflammation regulation. Recent studies suggest that intramuscular injection (IMI) of high-dose Vitamin D may offer additional benefits for cancer patients by supporting immune responses and inhibiting tumor progression. This article explores the scientific rationale, clinical evidence, and potential benefits of IMI Vitamin D in oncology.

Curcumin, the active compound in turmeric (Curcuma longa), is widely recognized for its anti-inflammatory, antioxidant, and anti-cancer properties. While oral curcumin supplements offer health benefits, their bioavailability is limited due to poor absorption and rapid metabolism. Intravenous (IV) curcumin overcomes this limitation by delivering higher concentrations directly into the bloodstream, making it a promising adjunct therapy in cancer treatment. This article explores the scientific mechanisms, clinical evidence, and potential benefits of IV curcumin for cancer patients.

Artesunate, a derivative of artemisinin extracted from the plant Artemisia annua, is traditionally known for its anti-malarial properties. However, recent studies suggest that IV artesunate possesses potential anti-cancer effects. Used as an adjunct therapy in integrative oncology, it has gained interest due to its selective toxicity against cancer cells. This article explores the scientific mechanisms, clinical evidence, and therapeutic potential of IV artesunate for cancer patients.

Glutathione is a powerful antioxidant found in every cell of the body, playing a crucial role in detoxification, immune function, and cellular protection. Intravenous (IV) glutathione therapy has gained attention in integrative oncology due to its potential anti-cancer properties, protection against chemotherapy toxicity, and support for overall well-being. This article explores the scientific mechanisms, clinical evidence, and benefits of IV glutathione therapy for cancer patients.

Alpha-Lipoic Acid (ALA) is a naturally occurring antioxidant and metabolic cofactor that plays a critical role in energy production, oxidative stress reduction, and mitochondrial function. Intravenous (IV) ALA therapy has gained attention in integrative oncology due to its potential anti-cancer effects, neuroprotective properties, and ability to reduce chemotherapy-induced side effects. This article explores the scientific mechanisms, clinical evidence, and therapeutic benefits of IV ALA therapy in cancer care.

Albumin is a crucial protein in the blood that plays a vital role in maintaining oncotic pressure, transporting nutrients, and supporting immune function. Intravenous (IV) albumin therapy is often used in cancer patients who experience hypoalbuminemia (low albumin levels) due to malnutrition, chronic inflammation, or cancer-related cachexia. This article explores the scientific mechanisms, clinical evidence, and therapeutic benefits of IV albumin therapy in cancer care.

In the realm of integrative oncology, intravenous (IV) high-dose vitamin C (HDIVC) has gained attention as a complementary treatment for cancer patients. Unlike oral vitamin C, which has limited absorption due to gastrointestinal regulation, IV administration allows for significantly higher plasma concentrations, potentially exerting pro-oxidant effects against cancer cells. But what does the science say? This article delves into the scientific rationale, clinical evidence, and potential benefits of HDIVC for cancer patients.